Aptose Biosciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.58 | -$0.58 | -$0.58 |
| Q2 2024 | 1 | -$0.64 | -$0.64 | -$0.64 |
| Q3 2024 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q1 2025 | 1 | -$0.69 | -$0.69 | -$0.69 |
| Q2 2025 | 1 | -$0.73 | -$0.73 | -$0.73 |
| Q3 2025 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q4 2025 | 1 | -$0.89 | -$0.89 | -$0.89 |
Aptose Biosciences Inc. Earnings Date And Information
Aptose Biosciences Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.43 earnings per share for the quarter, topping analysts' consensus estimates of $-0.58 by $0.15. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Aptose Biosciences Inc. has generated $-8 earnings per share over the last year ($-7.58 diluted earnings per share) and currently has a price-to-earnings ratio of -0.09. Aptose Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.
Aptose Biosciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.37 | $0 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.58 | -$0.43 | 0.15 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.82 | -$0.73 | 0.09 | $0 | |
| 04/29/2024 | Q4 2023 | -$1.55 | $712,206 | |||
| 11/09/2023 | Q3 2023 | -$2.16 | -$1.76 | 0.4 | $0 | |
| 08/10/2023 | Q2 2023 | -$2.09 | -$2.27 | -0.18 | $0 | |
| 05/08/2023 | Q1 2023 | -$1.80 | -$2.13 | -0.33 | $0 | |
| 03/23/2023 | Q4 2022 | -$1.68 | $0 | |||
| 11/01/2022 | Q3 2022 | -$1.80 | -$1.55 | 0.25 | $0 | |
| 08/02/2022 | Q2 2022 | -$1.95 | -$1.70 | 0.25 | $0 | |
| 05/09/2022 | Q1 2022 | -$2.25 | -$1.86 | 0.39 | $0 | |
| 03/22/2022 | Q4 2021 | -$2.70 | -$4.07 | -1.37 | $0 | |
| 11/12/2021 | Q3 2021 | -$1.95 | $0 | |||
| 08/03/2021 | Q2 2021 | -$2.70 | -$2.27 | 0.43 | $0 | |
| 05/04/2021 | Q1 2021 | -$2.55 | -$2.74 | -0.19 | $0 | |
| 03/23/2021 | Q4 2020 | -$2.40 | -$2.48 | -0.08 | $0 | |
| 11/10/2020 | Q3 2020 | -$2.70 | -$2.31 | 0.39 | $0 | |
| 08/04/2020 | Q2 2020 | -$2.25 | -$3.10 | -0.85 | $0 | |
| 05/05/2020 | Q1 2020 | -$1.50 | -$2.27 | -0.77 | $0 | |
| 03/10/2020 | Q4 2019 | -$2.10 | -$1.97 | 0.13 | $0 |
Aptose Biosciences Inc. Earnings: Frequently Asked Questions
-
When is Aptose Biosciences Inc.'s earnings date?
Aptose Biosciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates.
-
Did Aptose Biosciences Inc. beat their earnings estimates last quarter?
In the previous quarter, Aptose Biosciences Inc. (:APTO) reported $-0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.58 by $0.15.
-
How can I listen to Aptose Biosciences Inc.'s earnings conference call?
The conference call for Aptose Biosciences Inc.'s latest earnings report can be listened to online.
-
How can I read Aptose Biosciences Inc.'s conference call transcript?
The conference call transcript for Aptose Biosciences Inc.'s latest earnings report can be read online.
-
How much profit does Aptose Biosciences Inc. generate each year?
Aptose Biosciences Inc. (:APTO) has a recorded net income of $0. Aptose Biosciences Inc. has generated $-7.58 earnings per share over the last four quarters.
-
What is Aptose Biosciences Inc.'s price-to-earnings ratio?
Aptose Biosciences Inc. (:APTO) has a price-to-earnings ratio of -0.09 and price/earnings-to-growth ratio is -0.
